Voyager Therapeutics (VYGR) Free Cash Flow Growth (1y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 60.84% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 88.70% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -15.72% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 66.37% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 3.98% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 137.65% |
| 10 | Voyager Therapeutics | 230.25 Mn | 88.77 Mn | - | 13.28% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.28% |
| Dec 31, 2025 | -110.36% |
| Sep 30, 2025 | -10.73% |
| Jun 30, 2025 | -5.59% |
| Mar 31, 2025 | -168.08% |
| Dec 31, 2024 | 40.10% |
| Sep 30, 2024 | -29.28% |
| Jun 30, 2024 | -1,491.54% |
| Mar 31, 2024 | -53.98% |
| Dec 31, 2023 | -86.04% |
| Sep 30, 2023 | -32.45% |
| Jun 30, 2023 | 89.53% |
| Mar 31, 2023 | 259.83% |
| Dec 31, 2022 | -221.47% |
| Sep 30, 2022 | 22.86% |
| Jun 30, 2022 | 16.16% |
| Mar 31, 2022 | 260.47% |
| Dec 31, 2021 | 142.49% |
| Sep 30, 2021 | 28.51% |
| Jun 30, 2021 | -0.95% |
| Mar 31, 2021 | 29.68% |
| Dec 31, 2020 | 16.89% |
| Sep 30, 2020 | -59.27% |
| Jun 30, 2020 | 33.51% |
| Mar 31, 2020 | -124.21% |
| Dec 31, 2019 | -47.23% |
| Sep 30, 2019 | -1.47% |
| Jun 30, 2019 | -36.62% |
| Mar 31, 2019 | 157.60% |
| Dec 31, 2018 | -39.15% |
| Sep 30, 2018 | 5.71% |
| Jun 30, 2018 | -88.43% |
| Mar 31, 2018 | 381.83% |
| Dec 31, 2017 | 11.59% |
| Sep 30, 2017 | -83.46% |
| Jun 30, 2017 | -36.06% |
| Mar 31, 2017 | -73.31% |
| Dec 31, 2016 | -75.25% |
| Sep 30, 2016 | -52.55% |
| Jun 30, 2016 | -32.46% |
| Mar 31, 2016 | -115.44% |
| Dec 31, 2015 | -66.83% |